WilsonKC, KaminskyDA, MichaudG, SharmaS, NiciL, FolzRJ, et al. Restoring pulmonary and sleep services as the COVID-19 pandemic lessens. From an Association of Pulmonary, Critical Care, and Sleep Division Directors and American Thoracic Society–coordinated task force. Ann Am Thorac Soc, 2020; 17(11):1343-1351.
3.
SaundersMJ, HaynesJM, McCormackMC, StanojevicS, KaminskyDA. How local SARS-CoV-2 prevalence shapes pulmonary function laboratory protocols and practices during the COVID-19 pandemic. Chest, 2021; 160(4):1241-1244.
4.
CallJT, LeeAS, HaendelMA, ChuteCG, HelgesonSA. The effect of the COVID-19 pandemic on pulmonary diagnostic procedures. Ann Am Thorac Soc, 2022; 19(4):695-697.
5.
McGowanA, LavenezianaP, BayatS, BeydonN, BorosPW, BurgosF, et al. International consensus on lung function testing during the COVID-19 pandemic and beyond. ERJ Open Res, 2022; 8(1):00602-2021.
6.
HelgesonSA, LimKG, LeeAS, NivenAS, PatelNM. Aerosol generation during spirometry. Ann Am Thorac Soc, 2020; 17(12):1637-1639.
7.
HelgesonSA, LeeAS, PatelNM, TaylorBJ, LimKG, NivenAS. Cardiopulmonary exercise and the risk of aerosol generation while wearing a surgical mask. Chest, 2021; 159(4):1567-1569.
8.
SubatYW, HainyME, TorgerudKD, SajgalikP, GuntupalliSK, JohnsonBD, et al. Aerosol generation and mitigation during methacholine bronchoprovocation testing: infection control implications in the era of COVID-19. Respir Care, 2021; 66(12):1858-1865.
9.
SubatYW, MeyerTJ, TorgerudKD, LimKG, ScanlonPD, NivenAS. Use of a viral filter to reduce exposure to exhaled aerosol does not affect methacholine dose delivery during bronchoprovocation testing. Respir Care, 2022:respcare.09703 (in press).
10.
AriA, AtalayOT, HarwoodR, SheardMM, AljamhanEA, FinkJB. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care, 2010; 55(7):845-851.
11.
CoatesAL, WangerJ, CockcroftDW, CulverBH, DiamantZ, GauvreauG, et al. Bronchoprovocation Testing Task Force: Kai-Håkon Carlsen. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J, 2017; 49(5):1601526.
12.
CoatesA, CulverB, CockcroftD, HallstrandT, HaynesJ, KaminskyD, et al. Characterizing nebulizer performance for methacholine challenge tests. Am J Respir Crit Care Med, 2018; 198(8):988-990.
13.
LavoriniF, UsmaniOS, DhandR. Aerosol delivery systems for treating obstructive airway diseases during the SARS-CoV-2 pandemic. Intern Emerg Med, 2021; 16(8):2035-2039.
14.
TashkinDP, BarjaktarevicIZ. Nebulized treatments and the possible risk of coronavirus transmission: where is the evidence?. Chronic Obstr Pulm Dis, 2020; 7(3):136-138.
15.
LiuM, ChengSZ, XuKW, YangY, ZhuQT, ZhangH, et al. Use of personal protective equipment against coronavirus disease 2019 by health care professionals in Wuhan, China: cross-sectional study. BMJ, 2020; 369:m2195.
16.
DelclosGL, GimenoD, ArifAA, BurauKD, CarsonA, LuskC, et al. Occupational risk factors and asthma among health care professionals. Am J Respir Crit Care Med, 2007; 175(7):667-675.
17.
ChristianiDC, KernDG. Asthma risk and occupation as a respiratory therapist. Am Rev Respir Dis, 1993; 148(3):671-674.
18.
O'RiordanTG, SmaldoneGC. Exposure of health care workers to aerosolized pentamidine. Chest, 1992; 101(6):1494-1499.
19.
Dimich-WardH, WymerML, Chan-YeungM. Respiratory health survey of respiratory therapists. Chest, 2004; 126(4):1048-1053.
20.
DemersB. Drugs prescribed for patients shouldn't be taken by caregivers!. Chest, 2004; 126(4):1012-1013.
21.
HarnoisLJ, AlolaiwatAA, JingG, FinkJB, DhandR, LiJ. Efficacy of various mitigation devices in reducing fugitive emissions from nebulizers. Respir Care, 2022; 67(4):394-403.
